Experts divulge where the industry is outsourcing most frequently, when companies should outsource more, and when performing tasks in-house might be best.

Deciding Where to Outsource in Biopharma Development and Manufacturing

Automation of pharmaceutical packaging saves costs and time, say contract packagers./

Automating Packaging of Bio/Pharmaceuticals

CDMOs offer expertise and customization options for sponsors of orphan drugs.

Fostering Orphan Drugs

Topic

Articles

Agilent’s $725 million investment is designed to double its capacity to produce APIs.

Agilent Invests $725 Million in Nucleic Acid-based Therapeutics

CellVax Therapeutics has selected Theragent, a new CDMO, to manufacture clinical trial material for a new Phase II prostate cancer immunotherapy drug candidate.

CellVax and Theragent Form Manufacturing Pact for Novel Cancer Immunotherapy Drug Candidate

Ravi Samavedam is chief innovation officer at Azzur Group.

In the all-too-common debate over building lab facilities versus outsourcing, the best strategy may be the middle ground: licensing.

Threading the Needle Between DIY and CDMO

Scorpion’s new facility is designed for the development and manufacturing of clinical and commercial-scale biologic drugs.

Scorpion Biological Services Opens San Antonio Biologics Facility

Steriline will be exhibiting its vial filling and capping machine (VFCM100) under double-wall isolator for aseptic filling at CPHI 2022 in Frankfurt, Germany, on Nov. 1–3, 2022.

Steriline Showcases Filling Equipment at CPHI 2022

The company is expanding its contract development and manufacturing services for parenteral drugs to global customers.

Terumo Pharmaceutical Solutions Expands CDMO Services

Lisete Pinto is Product Development and Technical Support senior manager at Recipharm.

In this article, the potential pitfalls of technology transfers are discussed as well as ways to ensure a smooth transition.

Addressing the Key Pitfalls Hindering Technology Transfer Success

The CPHI Annual Report 2022 predicts cash reserves from venture capitalists and private equities will drive expansion in the demand for contract research organizations and contract development and research organizations.

Venture Capital Funding to Fuel Pharma Outsourcing

Under two new agreements, Societal CDMO will offer analytical, technical transfer, formulation, manufacturing, and packaging services for novel therapeutics.

Societal CDMO Signs Multiple CDMO Service Agreements

Aragen’s new 12,000 ft² facility will include various dosage form capabilities, including oral solids, liquids, topicals, and films.